Report
Michael Waterhouse
EUR 100.00 For Business Accounts Only

PerkinElmer Raises 2018 Guidance Following Strong 1Q Revenue Growth

PerkinElmer increased its 2018 revenue and adjusted EPS outlook above our previous forecasts following strong top-line growth during the first quarter. We anticipate a slight increase to our fair value estimate after we update our assumptions, and we are leaving our no-moat rating intact. Higher organic revenue growth from the acquired Euroimmun assets and a foreign exchange benefit prompted management to raise its 2018 revenue outlook by roughly $70 million to $2.8 billion (versus our prior $2....
Underlying
PerkinElmer Inc.

PerkinElmer is a provider of products, services and solutions for the diagnostics, life sciences and applied markets. The company operates in the following segments: Discovery and Analytical Solutions and Diagnostics. The company's Discovery and Analytical Solutions segment serves the life sciences and applied markets. The life sciences market consists of the life sciences research market and laboratory services market whereas the applied markets consist of environmental, food and industrial markets. In its Diagnostics segments, the company provides instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research personnel to help improve the health of families.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Michael Waterhouse

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch